Certain Shares of Biosergen AB are subject to a Lock-Up Agreement Ending on 4-OCT-2023. These Shares will be under lockup for 365 days starting from 4-OCT-2022 to 4-OCT-2023.

Details:
Östersjöstiftelsen, Rosetta Capital, and Peder M. Andersen has undertaken not to sell any shares or other securities in the Company for a period of 12 months through a so-called lock-up agreement. The share holdings of Östersjöstiftelsen, Rosetta Capital, and Peder M. Andersen corresponds to approximately 79 percent of the Company's outstanding shares.